These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19646753)

  • 1. Acute myeloid leukemia and ischemic heart disease successful first line treatment with clofarabine as single agent.
    Capria S; Trisolini SM; Matturro A; Santini L; Cardarelli L; Foà R; Meloni G
    Leuk Res; 2009 Dec; 33(12):e230-1. PubMed ID: 19646753
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
    Larson ML; Venugopal P
    Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of molecular relapse in patients with acute myeloid leukemia using clofarabine monotherapy.
    Racil Z; Toskova M; Dvorakova D; Jeziskova I; Razga F; Buresova L; Timilsina S; Mayer J
    Am J Hematol; 2012 Feb; 87(2):211-3. PubMed ID: 22052688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofarabine for the treatment of adult acute myeloid leukemia.
    Thomas X; Raffoux E; Elhamri M; Lobe I; Cannas G; Dombret H
    Future Oncol; 2009 Oct; 5(8):1197-210. PubMed ID: 19852733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
    Tran H; Yang D
    Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
    Kantarjian HM; Erba HP; Claxton D; Arellano M; Lyons RM; Kovascovics T; Gabrilove J; Craig M; Douer D; Maris M; Petersdorf S; Shami PJ; Yeager AM; Eckert S; Abichandani R; Faderl S
    J Clin Oncol; 2010 Feb; 28(4):549-55. PubMed ID: 20026805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Clofarabine in the treatment of adults with acute myeloid leukemia.
    Fozza C
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):237-45. PubMed ID: 25457773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clofarabine activity in childhood and adult acute leukemia: individual tumor response study.
    Styczynski J; Gil L; Derwich K; Wachowiak J; Balwierz W; Badowska W; Krawczuk-Rybak M; Matysiak M; Wieczorek M; Balcerska A; Sonta-Jakimczyk D; Stefaniak J; Kowalczyk J; Urasinski T; Sobol G; Komarnicki M; Wysocki M
    Anticancer Res; 2009 May; 29(5):1643-50. PubMed ID: 19443380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofarabine for treatment of acute lymphoblastic leukaemia in adults.
    Rodríguez Vargas B; Sánchez Cuervo M; Bermejo Vicedo T
    Farm Hosp; 2011; 35(1):47-9. PubMed ID: 20673734
    [No Abstract]   [Full Text] [Related]  

  • 10. European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy.
    Burnett AK; Russell NH; Kell J; Dennis M; Milligan D; Paolini S; Yin J; Culligan D; Johnston P; Murphy J; McMullin MF; Hunter A; Das-Gupta E; Clark R; Carr R; Hills RK
    J Clin Oncol; 2010 May; 28(14):2389-95. PubMed ID: 20385984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
    Bonate PL; Arthaud L; Cantrell WR; Stephenson K; Secrist JA; Weitman S
    Nat Rev Drug Discov; 2006 Oct; 5(10):855-63. PubMed ID: 17016426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine: in search of combinations for the treatment of patients with high-risk acute myeloid leukemia.
    Musto P; Ferrara F
    Cancer; 2008 Oct; 113(8):1995-8. PubMed ID: 18780321
    [No Abstract]   [Full Text] [Related]  

  • 13. Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed acute myeloid leukaemia.
    Williams JS; Mufti GJ; Powell S; Salisbury JR; Higgins EM
    Clin Exp Dermatol; 2007 Jul; 32(4):395-7. PubMed ID: 17376213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine for the treatment of acute lymphoblastic leukemia.
    Jeha S; Kantarjian H
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):113-8. PubMed ID: 17288522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of clofarabine in acute myeloid leukemia.
    Ghanem H; Kantarjian H; Ohanian M; Jabbour E
    Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine: a size that fits all, may not fit all.
    Vij R
    Leuk Lymphoma; 2009 Mar; 50(3):309-10. PubMed ID: 19347718
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine.
    Jeha S
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1137-44, viii. PubMed ID: 19825457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of complete remission using single agent clofarabine in a patient with primary refractory acute myeloblaste leukemia.
    Douer D; Watkins K; Levine AM; Weiss JM; Marshall LC; Craig AR
    Leuk Lymphoma; 2003 Dec; 44(12):2135-6. PubMed ID: 14959859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine in refractory Langerhans cell histiocytosis.
    Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
    Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.
    Burnett AK; Russell NH; Hunter AE; Milligan D; Knapper S; Wheatley K; Yin J; McMullin MF; Ali S; Bowen D; Hills RK;
    Blood; 2013 Aug; 122(8):1384-94. PubMed ID: 23838349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.